We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$722M
AUM Growth
-$5.37M
Cap. Flow
+$9.35M
Cap. Flow %
1.3%
Top 10 Hldgs %
34.36%
Holding
174
New
12
Increased
38
Reduced
77
Closed
6

Top Buys

Rank Stock Value
1
MCO icon
Moody's
MCO
+$4.85M
2
ARCB icon
ArcBest
ARCB
+$3.28M
3
RIVN icon
Rivian
RIVN
+$2.68M
4
APTV icon
Aptiv
APTV
+$2.38M
5
MMM icon
3M
MMM
+$2.33M

Sector Composition

Rank Sector Weight
1 Technology 24.38%
2 Healthcare 22.21%
3 Utilities 18.27%
4 Industrials 17.38%
5 Energy 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$36.8M 5.09%
374,988
-4,374
-1% -$414K
PFE icon
2
Pfizer
PFE
$159B
$32.4M 4.49%
626,041
-9,126
-1% -$474K
OGE icon
3
OGE Energy
OGE
$9.45B
$32.3M 4.48%
792,071
-11,493
-1% -$436K
BMY icon
4
Bristol-Myers Squibb
BMY
$136B
$28.2M 3.9%
385,471
-4,073
-1% -$273K
GLW icon
5
Corning
GLW
$128B
$24.8M 3.44%
672,841
+25,435
+4% +$993K
CSCO icon
6
Cisco
CSCO
$433B
$21.6M 2.99%
387,045
-3,299
-0.8% -$187K
XOM icon
7
ExxonMobil
XOM
$644B
$19.1M 2.64%
230,969
-552
-0.2% -$42.9K
INTC icon
8
Intel
INTC
$473B
$18.5M 2.57%
374,034
+3,632
+1% +$180K
IBM icon
9
IBM
IBM
$222B
$17.9M 2.49%
137,943
-2,597
-2% -$339K
NVS icon
10
Novartis
NVS
$292B
$16.4M 2.27%
186,419
+8,180
+5% +$708K
GSK icon
11
GSK
GSK
$102B
$16.1M 2.23%
296,146
-6,620
-2% -$360K
BCE icon
12
BCE
BCE
$21.9B
$15.9M 2.2%
286,005
-41,101
-13% -$2.18M
MDU icon
13
MDU Resources
MDU
$4.16B
$14.7M 2.03%
1,447,362
+66,864
+5% +$708K
MMM icon
14
3M
MMM
$89.9B
$13.9M 1.93%
111,625
+17,515
+19% +$2.33M
SLB icon
15
SLB Ltd
SLB
$85.1B
$13.3M 1.84%
321,654
-4,047
-1% -$159K
HE icon
16
Hawaiian Electric Industries
HE
$1.97B
$13.1M 1.82%
310,157
-3,525
-1% -$147K
XRAY icon
17
Dentsply Sirona
XRAY
$2.22B
$12.5M 1.73%
253,838
+19,105
+8% +$1.01M
D icon
18
Dominion Energy
D
$57.7B
$12.4M 1.72%
146,272
-2,010
-1% -$161K
BKH icon
19
Black Hills Corp
BKH
$5.55B
$12.2M 1.69%
158,333
-3,000
-2% -$209K
MSFT icon
20
Microsoft
MSFT
$3.81T
$11.6M 1.61%
37,637
+40
+0.1% +$12K
MRK icon
21
Merck
MRK
$366B
$11.1M 1.53%
134,887
+104
+0.1% +$8.2K
TEL icon
22
TE Connectivity
TEL
$58.7B
$10.9M 1.52%
83,592
+8,600
+11% +$1.23M
POR icon
23
Portland General Electric
POR
$5.83B
$10.9M 1.51%
197,909
-1,700
-0.9% -$89.4K
AGX icon
24
Argan
AGX
$5.86B
$10.8M 1.5%
266,010
+18,118
+7% +$710K
LGTY
25
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$10.4M 1.44%
498,271
-7,370
-1% -$163K

Similar funds

John G. Ullman & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, John G. Ullman & Associates held 174 positions worth $722M, down 0.74% from $727M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

John G. Ullman & Associates's Q1 2022 filing shows 12 new, 38 increased, 77 reduced and 6 closed positions. Its largest new stake was Moody's: 14,425 shares worth $4.87M. The largest sale was Elanco Animal Health, an estimated $4.59M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Utilities.

  • John G. Ullman & Associates's largest Q1 2022 buy was Moody's: 14,425 shares worth $4.87M.
  • John G. Ullman & Associates added most to 3M in Q1 2022, an estimated $2.33M increase.
  • John G. Ullman & Associates's biggest Q1 2022 reduction was Elanco Animal Health, cutting an estimated $4.59M.
  • John G. Ullman & Associates fully exited Chewy in Q1 2022, selling an estimated $2.85M.
  • John G. Ullman & Associates's ten largest holdings make up 34% of its $722M portfolio in Q1 2022.
  • John G. Ullman & Associates opened 12 new positions and closed 6 in Q1 2022.
  • John G. Ullman & Associates's portfolio value fell 0.74% quarter-over-quarter to $722M.

Based on John G. Ullman & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.